Caas Capital Management LP Abbott Laboratories Call Options Transaction History

Caas Capital Management LP

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2024 Apr 26, 2024	BUY	$109.52 - $120.96 $65,712 - $72,576	600 Added 13.33%	5,100 $579,000
Q4 2023 Feb 14, 2024	SELL	$90.19 - $110.4 $1.33 Million - $1.62 Million	-14,700 Reduced 76.56%	4,500 $495,000
Q3 2023 Nov 14, 2023	SELL	$95.53 - $114.62 $1.13 Million - $1.35 Million	-11,800 Reduced 38.06%	19,200 $1.86 Million
Q2 2023 Aug 14, 2023	BUY	$100.78 - $112.29 $292,262 - $325,641	2,900 Added 10.32%	31,000 $3.38 Million
Q1 2023 May 15, 2023	SELL	$96.86 - $114.01 $678,020 - $798,070	-7,000 Reduced 19.94%	28,100 $2.85 Million
Q4 2022 Feb 14, 2023	BUY	$95.06 - $111.52 $3.34 Million - $3.91 Million	35,100 New	35,100 $3.85 Million
Q4 2020 Feb 12, 2021	BUY	$105.0 - $114.42 $31.5 Million - $34.3 Million	300,000 Added 2941.18%	310,200 $34 Million
Q2 2020 Aug 14, 2020	BUY	$76.57 - $98.0 $781,013 - $999,600	10,200 New	10,200 $933,000

3,186

1.3B

8.74M

8.08M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $200B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Caas Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Caas Capital Management LP with notifications on news.